Council limits access to GLP‑1 drugs under city health plan after committee review

The Lake Forest City Council on Nov. 3 voted to modify access to GLP‑1 prescription drugs in the city’s employee health plans for plan year 2026 after a recommendation from the Personnel, Compensation and Administration (PCA) committee. The approved option (referred to as option 3 in staff materials) requires new users to enroll in the encircleRx program and meet defined entry and renewal criteria.

Key provisions: Under the approved changes, new users must meet a body‑mass‑index (BMI) threshold (a BMI of 32, or a BMI of 27 or greater with two qualifying comorbidities) and demonstrate prior attempts at behavioral modification (including a documented diet for at least three months) before coverage review. While on the program participants are expected to complete four weigh-ins and four app interactions every 30 days, and coverage renewal requires at least a 5 percent reduction in body weight from pre‑therapy measurement. Existing subscribers were exempted from the BMI entry requirement but must meet the program’s other requirements for renewal.

Financial impact: HR Director Ben Riesler presented three modeling scenarios. Maintaining current access (status quo) would have produced an estimated premium increase of about 8.6 percent (roughly $375,826). The committee-recommended option 3 was projected to limit the premium increase to about 7.1 percent (about $336,771), a near‑term premium savings of roughly $40,000 compared with status quo projections. The plan’s overall premium increases reflect broader factors including hospital consolidation in the region.

Council action: The council approved the plan modification by roll-call vote, 7–1. Councilors noted the item will remain under review and that the committee expects to revisit thresholds and program details during the next plan year as additional clinical data and pool-wide experience become available.